NetworkNewsBreaks – Zenosense, Inc. (ZENO) Targets Global POC Market with MIDS Cardiac Device
Healthcare technology company Zenosense (OTC: ZENO) is well positioned to capitalize on the projected growth in the global point-of-care (“POC”) diagnostics market, forecast to grow at a CAGR of 10 percent, from $23.71 billion in 2017 to $38.13 billion in 2022 according to a recent Research and Markets report (http://nnw.fm/o0fNq), through the development and commercialization of its MIDS Cardiac device. An article discussing the company reads: “MIDS’ key differentiator is its unique ability to detect and measure these assay beads by their total aggregated nano-magnetic signal, rather than conventional optical detection. Initial testing has demonstrated that this novel approach should…







